G-POEM + GES for Gastroparesis

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Baylor Research Institute
Must be taking: Anti-emetics, Prokinetics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two treatments for severe gastroparesis: G-POEM (Gastric Peroral Endoscopic Myotomy) and GES (Gastric Electrical Stimulation). Gastroparesis prevents the stomach from emptying food properly. Researchers aim to assess the safety and effectiveness of each treatment individually and in combination. The trial targets individuals with gastroparesis symptoms unresponsive to medication for over a year. Participants must have a confirmed diagnosis of delayed stomach emptying. As an unphased trial, this study provides a unique opportunity to explore innovative treatments for gastroparesis.

Do I need to stop my current medications for this trial?

The trial information does not specify if you need to stop your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that G-POEM, a procedure that aids food movement through the stomach, is generally safe for treating gastroparesis, a condition where food moves too slowly through the stomach. Studies indicate that G-POEM is almost always technically successful and safe for most patients who haven't improved with other treatments. While some individuals may still experience symptoms, many feel better after the procedure.

The combination of G-POEM and GES, a device using electrical signals to assist the stomach, also shows promising safety. This combination has long-term success rates between 50% and 77.5%, depending on the cause of gastroparesis. No major safety issues have been consistently reported, making these options worth considering for those with severe stomach problems.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments for gastroparesis because they offer new approaches to managing this challenging condition. Unlike traditional treatments like dietary changes and medications that mainly focus on symptom relief, G-POEM (Gastric Per-Oral Endoscopic Myotomy) directly targets the pyloric muscle to improve gastric emptying. This new mechanism of action could provide more effective relief for patients. Additionally, when combined with Gastric Electrical Stimulation (GES), there is potential for enhanced symptom control and improved quality of life. These innovative approaches could present significant advantages over existing treatments by addressing the root cause of the condition rather than just alleviating symptoms.

What evidence suggests that this trial's treatments could be effective for gastroparesis?

This trial will compare different treatment approaches for gastroparesis. Studies have shown that G-POEM, a procedure involving a small cut in the stomach lining to improve function, is quite effective, with success rates between 60.5% and 98.6%. Research indicates that patients often experience significant relief, with some studies noting improvements lasting up to 4 years. G-POEM has a strong track record, particularly for patients unresponsive to other treatments. In this trial, some participants will receive G-POEM alone, while others will receive GES, a treatment using electrical pulses to aid the stomach, alone. Additionally, a combination arm will provide both G-POEM and GES. Evidence suggests these methods effectively relieve symptoms, and the combination might be especially beneficial for severe cases. Overall, both treatments show promise in alleviating gastroparesis symptoms.14678

Who Is on the Research Team?

MW

Marc Ward, MD

Principal Investigator

Baylor Health Care System

Are You a Good Fit for This Trial?

This trial is for adults (18+) with severe gastroparesis symptoms that haven't improved after at least a year of standard treatments. Participants must have delayed stomach emptying confirmed by a special scan and be able to give consent.

Inclusion Criteria

* Patients must be able to consent
I have had gastroparesis symptoms for over a year that did not improve with standard treatments.
* Preoperative Gastroparesis Cardinal Symptom Index (GCSI) Score
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive G-POEM, GES, or a combination of both for gastroparesis management

12 months
Regular visits at baseline, 3, 6, 9, and 12 months

Follow-up

Participants are monitored for changes in gastroparesis symptoms, nutritional support status, and quality of life

12 months
Follow-up assessments at 6 and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • GES
  • G-POEM

Trial Overview

The study compares the safety and effectiveness of two procedures—gastric peroral endoscopic myotomy (G-POEM) and gastric electrical stimulation (GES)—alone or in combination, for treating stubborn gastroparesis.

How Is the Trial Designed?

4

Treatment groups

Active Control

Group I: GES onlyActive Control1 Intervention
Group II: Combination G-POEM and GESActive Control1 Intervention
Group III: Control groupActive Control1 Intervention
Group IV: G-POEM onlyActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+

Citations

1.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/31583465/

Clinical efficacy of gastric per-oral endoscopic myotomy (G ...

The pooled rate of clinical success, based on the 4-hour GES results, with G-POEM was 85.1% (95% CI 68.9-93.7, I2 = 74) and with surgical pyloroplasty was 84% ( ...

Long-term outcomes (≥3 years) after gastric peroral ...

We found that G-POEM is an effective long-term treatment option for patients with refractory gastroparesis, with technical and clinical success rates of 98.6% ...

A Clinical Review of Gastric Peroral Endoscopic Myotomy ...

Long‐term outcomes show sustained clinical success of 50%–77.5% at 3–4 years, influenced by disease etiology and neuromuscular progression. Endoluminal ...

G-POEM Options Equally Effective for Gastroparesis Symptom ...

Miller School researchers showed that both forms of the special, minimally invasive procedure for gastroparesis are equally effective.

Gastric peroral endoscopic myotomy for compassionate ...

Clinical success was achieved in 60.5% (23/38) of the patients. There were no differences in demographics, symptom duration, etiology of gastroparesis, baseline ...

S2189 Assessing the Impact and Safety of Redo G-POEM ...

Gastric peroral endoscopic myotomy (G-POEM) has been shown to alleviate symptoms of refractory gastroparesis in 48% to 71% of cases.

Efficacy and safety of gastric peroral endoscopic myotomy ...

Based on this meta-analysis, G-POEM is effective and safe for treating refractory gastroparesis irrespective of the etiology, with significant improvements in ...

8.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/34686412/

Efficacy and safety of gastric peroral endoscopic myotomy ...

Conclusion: G-POEM is an efficient and safe pylorus-directed endoscopic therapy for refractory gastroparesis with promising results. Keywords: ...